FR2004105A1 - Preparations pharmaceutiques - Google Patents

Preparations pharmaceutiques

Info

Publication number
FR2004105A1
FR2004105A1 FR6907111A FR6907111A FR2004105A1 FR 2004105 A1 FR2004105 A1 FR 2004105A1 FR 6907111 A FR6907111 A FR 6907111A FR 6907111 A FR6907111 A FR 6907111A FR 2004105 A1 FR2004105 A1 FR 2004105A1
Authority
FR
France
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6907111A
Other languages
English (en)
French (fr)
Inventor
Arthur Clark Cecil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Philips Gloeilampenfabrieken NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Gloeilampenfabrieken NV filed Critical Philips Gloeilampenfabrieken NV
Publication of FR2004105A1 publication Critical patent/FR2004105A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR6907111A 1968-03-15 1969-03-13 Preparations pharmaceutiques Withdrawn FR2004105A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB02704/68A GB1218102A (en) 1968-03-15 1968-03-15 Improvements in medicaments comprising drug/ion-exchange resin compounds

Publications (1)

Publication Number Publication Date
FR2004105A1 true FR2004105A1 (fr) 1969-11-21

Family

ID=10009580

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6907111A Withdrawn FR2004105A1 (fr) 1968-03-15 1969-03-13 Preparations pharmaceutiques

Country Status (5)

Country Link
BE (1) BE729827A (enExample)
DE (1) DE1908946A1 (enExample)
FR (1) FR2004105A1 (enExample)
GB (1) GB1218102A (enExample)
NL (1) NL6903782A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2373288A1 (fr) * 1976-11-26 1978-07-07 Pennwalt Corp Preparation pharmaceutique a liberation prolongee
EP0022117A3 (fr) * 1979-06-08 1981-11-11 Ady Trenker Résinate de metoclopramide et médicament le contenant

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
DE3317280A1 (de) * 1982-06-18 1983-12-22 Medical Research (Marketing) Pty. Ltd., North Ryde, New South Wales Mittel und dessen verwendung zur behandlung der kahnbein-erkrankung bei pferden
US4459278A (en) * 1983-03-07 1984-07-10 Clear Lake Development Group Composition and method of immobilizing emetics and method of treating human beings with emetics
US4762709A (en) * 1983-09-16 1988-08-09 Pennwalt Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona
US4859461A (en) * 1986-07-30 1989-08-22 Fisons Corporation Coatable ion exchange resins
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
US5219563A (en) * 1988-05-11 1993-06-15 Glaxo Group Limited Drug adsorbates
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
US5186930A (en) * 1988-11-14 1993-02-16 Schering Corporation Sustained release oral suspensions
US4999189A (en) * 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
PT93637A (pt) * 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
IT1241417B (it) 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
SE9103110D0 (sv) 1991-10-24 1991-10-24 Kabi Pharmacia Ab New drug formulation
JP3278192B2 (ja) * 1992-04-03 2002-04-30 ロート製薬株式会社 徐放性液剤
KR20010031911A (ko) 1997-11-10 2001-04-16 나까도미 히로다카 약제용 서방화제 및 그것을 함유한 서방성 의약조성물
DK2018160T3 (da) 2006-03-16 2012-02-06 Tris Pharma Inc Modificeret depotformuleringer indeholdende lægemiddel-ionbytterharpikskomplekser
WO2008042218A1 (en) 2006-10-03 2008-04-10 Tris Pharma, Inc. Formulations containing an ionic mineral-ion exchange resin complex and uses thereof
CA2880456A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2373288A1 (fr) * 1976-11-26 1978-07-07 Pennwalt Corp Preparation pharmaceutique a liberation prolongee
EP0022117A3 (fr) * 1979-06-08 1981-11-11 Ady Trenker Résinate de metoclopramide et médicament le contenant

Also Published As

Publication number Publication date
DE1908946A1 (de) 1969-10-16
BE729827A (enExample) 1969-09-15
GB1218102A (en) 1971-01-06
NL6903782A (enExample) 1969-09-22

Similar Documents

Publication Publication Date Title
FR2004105A1 (fr) Preparations pharmaceutiques
NL145757B (nl) Farmaceutische capsule.
NL152455B (nl) Medicinale spuit.
CH492607A (de) Dose
CH558178A (de) Moussierende zubereitungen.
BE752165A (fr) Preparations pharmaceutiques anesthesiques
BR6915242D0 (pt) Agentes terapeuticos
AT271993B (de) Fungitoxisches Mittel
FR2004418A1 (fr) Medicament ferrugineux
AT263453B (de) Fungitoxisches Mittel
AT262695B (de) Fungitoxisches Mittel
AT299552B (de) Pigmentzubereitungen
CH520470A (de) Pestizides Mittel
BE764768A (fr) Compositions pharmaceutiques
BE744083A (fr) Nouvelles preparations pharmaceutiques
FR2000053A1 (fr) Preparations pharmaceutiques
AT288779B (de) Fungitoxisches Mittel
BE772487A (fr) Compositions pharmaceutiques
CH524675A (de) Wässrige Elektrotauchlackzubereitungen
BR6905672D0 (pt) Draga cortadora aperfeicoada
CH519012A (de) Farbstoffpräparate
BR6910458D0 (pt) Preparacoes cosmeticas
AT301258B (de) Fungitoxisches Mittel
BE784835A (fr) Nouvelles preparations pharmaceutiques
FR2081518A1 (fr) Nouvelles preparations pharmaceutiques

Legal Events

Date Code Title Description
ST Notification of lapse